HLA-DOB and hepatocellular carcinoma: The set of 24 CpG sites hypermethylated in advanced HCC tumors are located in genes involved in immune response and adhesion (IL18BP, IPF1, HLA-DOB, CSPG2, GJB2 and PMP22), and the cell cycle (CCND2 and NTKR3).